Tiltan Pharma Overview
- Year Founded
-
2006
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Tiltan Pharma General Information
Description
Developer of a proprietary anti-angiogenic and immune-modulatory platform designed to offer innovative cancer therapies. The company's platform develops TL-118, is an oral drug combination with anti-cancer, antiangiogenic and immune-modulatory properties, enabling healthcare institutions to avail drugs to treat cancer effectively.
Contact Information
Website
www.tiltanpharma.comCorporate Office
- 2.4 Hi tech Village, Edmond Safra campus
- Givat Ram P.O. Box 39026
- Jerusalem 91390
- Israel
Corporate Office
- 2.4 Hi tech Village, Edmond Safra campus
- Givat Ram P.O. Box 39026
- Jerusalem 91390
- Israel
Tiltan Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 01-Sep-2019 | Completed | Out of Business | |||
| 3. Later Stage VC | 05-Feb-2014 | Completed | Generating Revenue | |||
| 2. Grant | 01-Feb-2009 | $1.2M | Completed | Startup | ||
| 1. Early Stage VC | 01-Jan-2007 | Completed | Startup |
Tiltan Pharma Patents
Tiltan Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2018069924-A1 | Non-cytotoxic combination therapies and uses thereof in the treatment of cancer | Inactive | 10-Oct-2016 | ||
| WO-2016166761-A1 | Combination therapies and uses thereof in the treatment of cancer | Inactive | 14-Apr-2015 | ||
| AU-2013208649-A1 | Combination therapy for the treatment of cancer | Active | 09-Jan-2012 | ||
| AU-2013208649-B2 | Combination therapy for the treatment of cancer | Inactive | 09-Jan-2012 | ||
| CA-2860473-A1 | Combination therapy for the treatment of cancer | Inactive | 09-Jan-2012 | A61K31/7068 |
Tiltan Pharma FAQs
-
When was Tiltan Pharma founded?
Tiltan Pharma was founded in 2006.
-
Where is Tiltan Pharma headquartered?
Tiltan Pharma is headquartered in Jerusalem, Israel.
-
What industry is Tiltan Pharma in?
Tiltan Pharma’s primary industry is Biotechnology.
-
Is Tiltan Pharma a private or public company?
Tiltan Pharma is a Private company.
-
What is Tiltan Pharma’s current revenue?
The current revenue for Tiltan Pharma is .
-
How much funding has Tiltan Pharma raised over time?
Tiltan Pharma has raised $1.5M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process